
亚太地区放射治疗市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(外照射放射治疗、体内放射治疗和全身放射治疗/放射性药物);产品(体外放射治疗产品、体内放射治疗产品、放射治疗软件等);应用(乳腺癌、肺癌、前列腺癌、结直肠癌、淋巴瘤、肝癌、甲状腺癌、脑癌、宫颈癌、脊柱癌等);最终用户(医院、放射治疗中心和专科诊所)
No. of Pages: 175 | Report Code: TIPRE00025048 | Category: Life Sciences
No. of Pages: 175 | Report Code: TIPRE00025048 | Category: Life Sciences
放射治疗主要用于控制肿瘤的生长,并尽量减少对周围正常和健康组织的暴露。放射治疗使用高能辐射(通常是 X 射线)来破坏癌细胞并治疗前列腺、乳房、头部和身体部位的肿瘤。颈部、肺部以及身体任何其他需要进行放射治疗的部位。过去几年,随着成像方式、强大的计算机、软件和传输系统的改进使技术成为可能,放射治疗取得了进展。
因此,预计该地区癌症患病率的上升将导致未来几年对放射治疗的巨大需求,预计将进一步推动放射治疗市场的发展。
在 COVID-19 时代,中国医院开发了一种系统,使弱势癌症患者能够继续接受高剂量的治疗-优质的医疗服务,在保护他们的同时优化他们的生存。这包括使用数字快速代码、发热门诊和优化调度。印度 COVID-19 危机期间,放射肿瘤科的患者数量较多,采取了以下策略:需要采取措施降低感染风险、根据优先级对治疗进行分类、修改放射治疗计划、学术会议以及放射肿瘤科新冠病毒阳性患者/人员的管理。因此,放射治疗市场因Covid -19而受到中等程度的影响。
亚太地区放射治疗市场预计将从2021年的12.421亿美元增长到2028年的19.386亿美元;预计 2021 年至 2028 年复合年增长率为 6.6%。在过去几年中,针对癌症早期检测以及癌症治疗和新技术开发的研究活动的投资有所增加。管理。与此同时,教育和研究中心、医疗保健机构和市场参与者正在积极参加许多会议和研讨会,以分享知识并展示新技术。此外,此类计划还显着有助于传播人们对放射治疗的认识,这最终将在预测期内推动市场发展。此外,2018年11月,北京全域医疗科技有限公司与Mevion Medical Systems在中国放射肿瘤学会年会上联合举办了中国紧凑型质子治疗趋势会议。此类会议可能会促进整个地区的创新和新产品开发。此外,预计研讨会将有助于产品增强,最终将在 2028 年推动放射治疗市场的发展。
从类型来看,外照射放疗细分市场在2020年亚太放疗市场中占据最大份额。从产品来看,外照射放疗细分市场占据了亚太地区放疗市场的最大份额。放射治疗产品细分市场在2020年亚太放射治疗市场中占据最大份额。从应用来看,乳腺癌细分市场在2020年亚太放射治疗市场中占据最大份额。从最终用户来看,医院细分市场占据了2020年亚太放射治疗市场最大份额。 2020年放疗市场份额更大。
准备本亚太地区放射治疗市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括:Siemens Healthineers AG、Accuray Incorporated、Sumitomo Heavy Industries, Ltd.、Elekta AB、Hitachi, Ltd.、Koninklijke Philips NV、Brainlab AG、Mevion Medical Systems 和 Varian Medical Systems, Inc.
按类型
span>
按产品
按应用
由最终用户
  ;
按国家/地区
p>
Strategic insights for Asia Pacific Radiotherapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,242.1 Million |
Market Size by 2028 | US$ 1,938.6 Million |
Global CAGR (2021 - 2028) | 6.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Radiotherapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Radiotherapy Market is valued at US$ 1,242.1 Million in 2021, it is projected to reach US$ 1,938.6 Million by 2028.
As per our report Asia Pacific Radiotherapy Market, the market size is valued at US$ 1,242.1 Million in 2021, projecting it to reach US$ 1,938.6 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The Asia Pacific Radiotherapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiotherapy Market report:
The Asia Pacific Radiotherapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Radiotherapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Radiotherapy Market value chain can benefit from the information contained in a comprehensive market report.